Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Head and Neck Squamous Cell Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00557206
What this trial is testing

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
NeoplasmsHead and Neck Neoplasms
Minneapolis Veterans Affairs Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT00337129
What this trial is testing

S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 42
Large-scale testing (Phase 3)Looking for participantsNCT06644781
What this trial is testing

Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Daiichi Sankyo 510
Testing effectiveness (Phase 2)Study completedNCT02124707
What this trial is testing

Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHN

Who this might be right for
Head and Neck CancerSquamous Cell Carcinoma of the Head and Neck
UNC Lineberger Comprehensive Cancer Center 14
Early research (Phase 1)Ended earlyNCT04659369
What this trial is testing

Study of Pharmacokinetic, Safety, Immunogenicity and Efficacy of CMAB819 and Nivolumab in R/M HNSCC

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Taizhou Mabtech Pharmaceutical Co.,Ltd 21
Testing effectiveness (Phase 2)UnknownNCT02054442
What this trial is testing

The Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Radboud University Medical Center 52
Testing effectiveness (Phase 2)Study completedNCT00526149
What this trial is testing

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Who this might be right for
Breast CancerEndometrial CancerHead and Neck Cancer+3 more
European Organisation for Research and Treatment of Cancer - EORTC 76
Testing effectiveness (Phase 2)Study completedNCT04260126
What this trial is testing

Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC

Who this might be right for
Metastatic Head and Neck CancerRecurrent Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
PDS Biotechnology Corp. 95
Testing effectiveness (Phase 2)WithdrawnNCT05879484
What this trial is testing

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

Who this might be right for
Sinonasal CancerSquamous Non-small Cell Lung CancerLung Cancer+3 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00397904
What this trial is testing

Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin

Who this might be right for
Esophageal CancerGastric Cancer
Memorial Sloan Kettering Cancer Center 16
Testing effectiveness (Phase 2)UnknownNCT01267578
What this trial is testing

Peptide Vaccination in Treating Patients With Esophageal Cancer (STF-II)

Who this might be right for
Esophageal Cancer
University of Yamanashi 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04590963
What this trial is testing

Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 370
Testing effectiveness (Phase 2)Study completedNCT01854749
What this trial is testing

S1 Combined With Cisplatin in Treatment of Recurrence/Metastasis of ESCC Open-label Single Center Phase II Clinical Study

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07659678
What this trial is testing

CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Head and Neck Squamous Cell Carcinoma HNSCC
Washington University School of Medicine 90
Early research (Phase 1)Study completedNCT02636036
What this trial is testing

Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors

Who this might be right for
Colorectal CancerSquamous Cell Carcinoma of the Head and NeckEpithelial Tumor
Akamis Bio 51
Not applicableStudy completedNCT04540588
What this trial is testing

Retreatment With Intratumoral Diffusing Alpha Radiation Emitters

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 2
Not applicableActive Not RecruitingNCT03712566
What this trial is testing

Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy

Who this might be right for
CancerEsophagus Squamous Cell CarcinomaSquamous Cell Carcinoma of the Head and Neck+2 more
University Health Network, Toronto 39
Testing effectiveness (Phase 2)Study completedNCT00446446
What this trial is testing

PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)

Who this might be right for
CancerCarcinomaHead and Neck Cancer+6 more
Amgen 52
Testing effectiveness (Phase 2)Study completedNCT04313504
What this trial is testing

Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC

Who this might be right for
Head and Neck Cancer
Trisha Wise-Draper 10
Testing effectiveness (Phase 2)Ended earlyNCT03655444
What this trial is testing

Abemaciclib + Nivolumab in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed or Recurred Within Six Months After Platinum-based Chemotherapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine 6
Next Page